Blood pressure treatment goals in hypertension

Therapeutic Advances in Cardiovascular Disease

Volumn 10, Issue 6, 2016, Pages 332-337

  Düsing, Rainer ^a  

^a Hypertoniezentrum Bonn Schwerpunktpraxis Kardiologie Angiologie Rehabilitation   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGE; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CONGESTIVE HEART FAILURE; CORRELATIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; BLOOD PRESSURE; DRUG EFFECTS; HEART FAILURE; SYSTOLE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HEART FAILURE; HUMANS; HYPERTENSION; SYSTOLE;

EID: 84994820165     PISSN: 17539447     EISSN: 17539455     Source Type: Journal    
DOI: 10.1177/1753944716636035     Document Type: Review

References (22)

1. ACCORD Study Group (2010) Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 62: 1575-1585.
2. Bangalore S., Gong Y., Cooper-DeHoff R., Pepine C., Messerli F., (2014) Eighth Joint National Committee panel recommendation for blood pressure targets revisited: results from the INVEST Study. J Am Coll Cardiol 64: 784-793.
3. Beckett N., Peters R., Fletcher A., Staessen J., Liu L., Dumitrascu D., et al. for the HYVET Study Group (2008) Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358: 1887-1898.
4. D'Agostino R., Belanger A., Kannel W., Cruickshank J., (1991) Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study. Br Med J 303: 385-389.
5. James P., Oparil S., Carter B., Cushman W., Dennison-Himmelfarb C., Handler J., et al. (2014) 2014 Evidence-based guideline for the management of high blood pressure in adults. Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). J Am Med Assoc 311: 507-520.
6. Kjeldsen S., Narkiewicz K., Hedner T., Mancia G., (2016) The SPRINT study: outcome may be driven by difference in diuretic treatment demasking heart failure and study design may support systolic blood pressure target below 140 mmHg rather than below 120 mmHg. Blood Press. 2016. [Epub ahead of print]
7. Kostis J., Davis B., Cutler J., Grimm R. Jr, Berge K., Cohen J., et al. (1997) Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. J Am Med Assoc 278: 212-216.
8. Mancia G., Fagard R., Narkiewicz K., Redón J., Zanchetti A., Böhm M., et al. (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension. J Hypertens 31: 1281-1357.
9. Messerli F., Panjrath G., (2009) The J-curve between blood pressure and coronary artery disease or essential hypertension. Exactly how essential? J Am Coll Cardiol 54: 1827-1834.
10. Messerli F., Mancia G., Conti R., Hewkin A., Kupfer S., Champion A., (2006) Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 144: 884-893.
11. Mossello E., Pieraccioli M., Nesti N., Bulgaresi M., Lorenzi C., Caleri V., et al. (2015) Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs. J Am Med Assoc Intern Med 175: 578-585.
12. Peng J., Lu F., Wang Z., Zhong M., Sun L., Hu N., et al. (2014) Excessive lowering of blood pressure is not beneficial for progression of brain white matter hyperintensive and cognitive impairment in elderly hypertensive patients: 4-year follow-up study. J Am Med Dir Assoc 15: 904-910.
13. Pickering T., Hall J., Appel L., Falkner B., Graves J., Hill M., et al. (2005) Recommendations for blood pressure measurement in humans and experimental animals. Part 1: Blood pressure measurement in humans. A Statement for Professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 111: 697-716.
14. Prospective Studies Collaboration (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360: 1903-1913.
15. SHEP Cooperative Research Group (1991) Final results of the Systolic Hypertension in the Elderly Program (SHEP). J Am Med Assoc 265: 3255-3264.
16. SPRINT Research Group (2015) A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373: 2103-2116.
17. SPS3 Study Group (2013) Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet 382: 507-515.
18. Thomopoulosa C., Parati G., Zanchetti A., (2016) Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure-meta-analyses of randomized trials. J Hypertens 34: 373-384.
19. Williams B., (2009) Hypertension and the 'J-curve'. J Am Coll Cardiol 54: 1835-1836.
20. Wright J. Jr, Fine L., Lackland D., Ogedegbe G., Dennison-Himmelfarb C., (2014) Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 or older: the minority view. Ann Intern Med 160: 499-503.
21. Zanchetti A., Liu L., Mancia G., Parati G., Grassi G., Stramba-Badiale M., et al. (2014) Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial. J Hypertens 32: 1888-1897.
22. Zanchetti A., Liu L., Mancia G., Parati G., Grassi G., Stramba-Badiale M., et al. (2016) Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. J Hypertens 34: 393-396.